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Background/aims: There is ample consensus that there is a neurophysiological basis for the eating 
disorders (ED). Traits of personality translate into behavioural traits, purging being a well defined 
transversal example. Direct implication of steroid hormones on  ED has been seldom studied, despite 
their effects on behaviour.  
Methods: After psychological interview analysis 57 ED female patients (31 purgative and 26 non-
purgative), and 17 female controls were studied. Metabolic parameters and analysis of androgen, 
estrogen and glucocorticoid hormones were determined in parallel to the psychopathological profile 
(EDI-2 and SCL-90-R) and anthropometric measurements.  
Results: Psychometric tests showed clear differences between ED and controls, but there were few 
hormonal-metabolic significant differences. In purgative ED there were repeated (significant) positive 
correlations with CBG, and negative with SHBG, versus eating and general psychopathology. In non-
purging, there were positive correlations for deoxycortisol, free fatty acids, albumin and negative for 
aspartate aminotransferase and psychopathological traits.  
Conclusion: The data hint at CBG/corticosteroids and sexual hormones/SHBG to be involved in purging 
behaviour and its psychopathology and severity scores. Correlations of selected psychometric data and 
the CBG/SHBG levels in purging may eventually result in clinical markers. This approach may provide 





Homonal and metabolic changes in eating disorders (ED) have widely been described and studied in 
the literature (1,2). Their metabolic causes, however, have been seldom analyzed, mainly because of 
the limited availability of data, and the wide complexity of the populations studied (3). This is in part a 
consequence of diagnostic of the ED is, in itself, a fairly complex issue (4) and the intrinsic variability of 
most metabolic and hormonal parameters in human populations that are otherwise “normal”. 
Nevertheless, this relationship may run deeper than usually assumed: the common occurrence of 
amenorrhea in deeply affected anorectic individuals suggests that at least the hypothalamus-pituitary-
gonadal axis is affected and their biological implications known.  
Biological vulnerability in ED 
Although genetic predisposition to ED has received considerable attention (5,6), is difficult to arrive at 
clear conclusions because of the variability on the manifestations, intensity and symptom-focusing of 
these disorders (7). Most of these studies only hint at increased frequency (or predisposition) because 
of the presence of certain alleles in a number of genes related with control of energy, appetite, behavior 
or other pathways (8,9), but there is not a clear-cut direct relationship with the ED (10,11). The intrinsic 
variability that characterizes any group of humans (height, weight, metabolic parameters, hormonal 
cycles), even if limited to one sex and a fairly narrow limit of age, makes very difficult to find well-defined 
group differences in parameters that otherwise are subjected to homoeostatic control and tend to 
remain stable in spite of powerful manipulation. This problem is compounded by the intrinsic variability 
added by the analytical methods (in fact of any analytical method). 
The markedly individual or personal nature of human psychological makeup is a key factor adding 
variability to any group-based analysis of metabolic-psychological relationships. The complexity of the 
etiology and even manifestations of eating diseases can be simplified by ascribing each patient to a 
particular category of the ATP-III, but the continuum of individual patient characteristics will no doubt 
affect not only psychological reactions but also hormonal correlates inducing metabolic consequences, 
thus increasing the “gray zone” between specific diagnostic groups. The obvious consequence is the 
relative lack of studies showing clear metabolic changes attributable to specific manifestations of eating 
disorders (12,13). There are a few studies showing the tip of the iceberg (14), and it is generally 
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acknowledged that metabolic correlates of eating diseases can be first-order elements both for their 
diagnostic and as key elements for understanding their pathogenic mechanisms (15). 
Hormonal correlates and ED 
There are a number of studies linking metabolic and hormonal changes with ED, both in humans and 
animal models (16), but changes induced by ED on the main hormonal and metabolic parameters have 
been only sparsely studied. Steroidal hormones, a case in point, are seldom analyzed in blocs including 
a number of different molecular species as a way to better understand the changes of their patterns in 
disease. The rapid inter-conversion of a number of corticosteroids (17), and, especially androgen and 
estrogen hormones and their precursors are a key characteristic of their function and a powerful means 
for their control. Although, hormonal profiles and influence in ED have widely been studied, such as 
estrogens (3,18,19), androgens (20), altered hypothalamic-pituitary adrenal (21) and hypothalamic-
pituitary-gonadal axes functions (15) their relationships with specific phenotypical characteristics of ED 
have been seldom described. Although specific clinical traits such as purging behaviour have frequently 
been associated to higher psychopathology and poorer prognosis (21-24), their potential association 
with hormonal functioning has rarely been investigated. 
The division of ED along the purging/non-purging line is based on its clear association with medical risk 
(25) and follows previous studies in which this subtyping has been widely used (26), on the basis of 
medical consequences and empirical phenotyping (27) 
Aims of the study 
Given the current gaps in the literature, the goal of the present study was to overcome the limitations of 
the previous studies by comparing ED individuals and healthy eating controls, across a broad range of 
hormonal components (Supplemental Figure 1): i.e. the key steroidal hormones and the transporting 
globulins: SHBG (28) and CBG (29), together with phenotypical characteristics (namely purging 
behaviour, clinical symptoms and general psychopathology).  
Our specific goals were threefold and included: 1) to explore the distribution of hormonal parameters in 
a sample of EDs individuals and to analyze whether they are different when compared with healthy-
eating controls; 2) to compare whether hormonal parameters differ between purging and non-purging 
ED, as a way to determine the eventual implication of steroid hormones in the manifestation of this 
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marker symptom; 3) to assess the relationship of differential hormonal features with other phenotypical 
traits in ED (clinical and psychopathological variables);  
We hypothesized that hormonal function may be associated not only to ED categories but to some 
specific ED clinical features associated to severity (namely to ED severity and general 
psychopathology). This approach opens a new avenue for the study of the pathogenicity of eating 
disorders and their metabolic correlates in populations otherwise diverse, and would allow us to 
distinguish a specific metabolic-hormonal pattern in ED.  
 
Materials and Methods 
Participants 
The final sample included 57 female ED patients (12 AN and subtreshold AN (21.0%), 31 BN and 
subthreshold BN (54.4%), and 14 with Eating Disorders Non Otherwise Specified-EDNOS (24.6%), 
[including 5 Binge Eating Disorder (8.8%)]. In total there were 35 purgative and 22 non purgative ED 
patients, consecutively admitted to the Eating Disorders Unit in the Department of Psychiatry at the 
University Hospital at Bellvitge (Barcelona, Spain). All participants were diagnosed according to DSM-IV 
criteria, using a semi-structured clinical interview [SCID-I] (30), conducted by experienced psychologists 
or psychiatrists. A total of 17 health-eating women, the comparison group (CG), were volunteers 
recruited from the staff of our Centers. The exclusion criteria were: current treatment with hormones 
(including anovulatory combinations), diabetes and other metabolic diseases (including polycystic ovary 
syndrome), drug consumption (including tobacco and alcohol), as well as other infectious, hormonal or 
metabolic diseases and lifetime ED in the case of CG individuals. The Ethics Committee of the 
University Hospital at Bellvitge approved this study, and informed consent was obtained from all 
participants. 
Psychometrical measures 
--Eating Disorders Inventory 2 (EDI-2) 
The EDI-2 (31) is a reliable and validated 91-item multidimensional self-report questionnaire that 
assesses different cognitive and behavioral characteristics, which are typical for eating disorders The 
questions are answered on a 6-point Likert scale. This instrument was validated in a population of 
6 
 
Spaniards (32) and had a mean internal consistency of 0.63 (coefficient alpha). Inter-rates reliability 
ranged between good to excellent (values were 0.77 to 0.96).  
--Symptom Checklist- Revised (SCL-90-R) 
We used the SCL-90-R (33) to assess a broad range of psychopathological symptoms. This test 
contains 90 items and helps to measure 9 primary symptom dimensions. In addition, it includes three 
global indices: 1) a global severity index (GSI), designed to measure overall psychological distress; 2) a 
positive symptom distress index (PSDI), designed to measure the intensity of symptoms; and 3) a 
positive symptom total (PST). The global severity index can be used as a summary of the test..This 
scale has been validated in a population of Spaniards (34), and had a mean internal consistency of 0.75 
(coefficient alpha).  Inter-rates reliability was between good to excellent, with values comprised between 
0.70 and 0.90. 
Procedure 
Experienced psychologists and psychiatrists with master’s or doctoral degrees (all them extensively 
trained in the use of the instruments) completed the clinical assessment during two structured face-to 
face interviews, before any psychological or pharmacological treatment was initiated. The first interview 
included questions about regularity of their menses and the mean duration and time of their ovulation 
cycle at the moment of the analyses. In addition to the clinical interview, demographic information was 
obtained through self report questionnaires.  
In this session, basic anthropological measurements were carried out. Body weight and height were 
measured using standard procedures, and were used to calculate the body mass index (BMI) in kg/m2. 
The percentage of body fat was estimated with a bioimpedance system (Body Mass Analyzer BC-
418MA, Tanita Corp. Tokyo, Japan).  
Hormonal and metabolic measurements 
Venous blood samples were taken in the morning, after an overnight fast; serum was separated and 
stored at -80ºC; later it was used for the analysis of glucose, total cholesterol, triacylglycerols, bilirubin, 
albumin, total serum protein, urea, alanine and aspartate aminotransferases, lactate dehydrogenase 
and ketone bodies using dry chemistry strips (Spotchem Strips, Menarini, Firenze. Italy); free fatty acids 
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were measured with a kit (NEFA kit, Wako, Osaka Japan). Steroid hormones (except hormone sulfates) 
were measured by HPLC-MS/MS following the procedure described in the Supplemental Nethods.  
Specific radioimmunoanalysis / ELISA kits were used for the measurement of: insulin (RIA HI-14K, 
Millipore, Billerica MA USA). sex hormone-binding globulin (SHBG) (IRMA KP32CT, RADIM, Roma 
Italy). corticosteroid-binding globulin (CBG) (RIA KIP1809, BioSource, Nivelles Belgium), estrone sulfate 
(RIA DSL-5400 Diagnostic Systems Laboratories, Webster Texas USA) and dehydroepiandrosterone 
(DHEA) sulfate (RIA DSL-3500 Diagnostic Systems Laboratories). The HOMA value was calculated 
from insulin and glucose data (35). 
Statistical analyses 
The statistical analysis was carried out with PASW17 statistics (SPSS system). T-TEST procedures 
(and the non-parametrical Mann-Whitney test for data with high asymmetries) explored differences in 
clinical and psychological measures between groups (purging vs non-purging and ED vs CG). 
Heterotypical association between hormones and metabolic measures (considered as predictors) with 
psychometrical scores (considered as outcomes) was valued through multiple lineal regressions. One 
independent model was defined for each psychometrical outcome, entering simultaneously the set of 
hormones or metabolic incomes (ENTER procedure). Beta-coefficients obtained with these models 
valued the specific contribution of each predictor on the criteria, adjusted to the presence of the other 
variables considered of the same set; the R2 coefficient valued the total predictive accuracy of the 
model.  
Homotypical association between variables pertaining to the same group (hormones. metabolic and 
psychometrical) was valued with partial-correlations. These coefficients measures the degree of 
association between pairs of variables controlling (adjusting) the effect of other covariates. In this study, 
one independent partial-r-coefficient was obtained for each pair of variables considering as covariates 
the rest of variables of the same group different from zero. Paired correlations were considered relevant 






Clinical, general psychopathology, anthropometric and metabolic description among the groups 
The mean values obtained among the ED groups (purging vs. non-purging) for all anthropometric 
values are shown in Supplemental Table 1. There were no significant differences between groups 
except for higher body fat in non-purging than in CG. Table 1 presents the comparison of the EDI2 and 
SCLR90R test scores between the three experimental groups. There were significant differences for all 
items between ED as a whole and for both purging and non-purging women. However, no differences 
were observed between both ED groups. The results for SCLR90R test were fully comparable to those 
obtained with the EDI2 test: there were significant differences versus CG for all ED and the subgroups 
purging and non-purging, but there were no differences between these two subgroups. 
Table 2 shows the serum steroid.hormone related parameters in CG, ED and the two subgroups of 
purging and non-purging ED women. The differences observed were sparse. When considered the 
whole of ED versus CG estrone sulfate and cortisone levels were lower in ED, and androstenedione, 
higher. Comparison of CG and non-purging was coincident with all ED in estrone sulfate and 
androstenedione, but not in cortisone: however the differences versus CG were significant for β-
estradiol. SHBG levels were higher in purging women than in CG. There were significant differences 
between purging and non-purging groups for androstenedione and DHEA-sulfate, with levels higher, in 
both cases, in non-purging women.  
Supplemental Table 2 depicts the serum metabolite data for ED and CG. There were no statistically 
significant differences between groups for any of the parameters studied. 
Interaction between hormonal-metabolic parameters and ED and general psychopathology 
between purging and non-purging ED 
The analysis of paired correlation data applied to the EDI2 psychometric aspects showed a 
considerable number of significantly interrelated parameters (Table 3). Thus in ED non-purging women, 
BMI, body weight and body fat were positively correlated to body dissatisfaction and bulimia. 
Deoxycortisol was correlated to interpersonal distrust, ineffectiveness, impulse regulation, ascetism and 
social insecurity. Free fatty acids were correlated to ineffectiveness, impulse regulation, ascetism, and 
social insecurity. Other correlations were limited to one or two factors: pregnelonone to interpersonal 
distrust, progesterone to impulse regulation, androstenedione to ascetism, alanine aminotransferase to 
bulimia, albumin to perfectionism and both urea and plasma proteins to eating disorder inventory total.  
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The pattern of negative correlations for ED non-purging women were more limited: aspartate 
aminotransferase to interoceptive awareness, interpersonal distrust, ineffectiveness, impulse regulation, 
social insecurity, and eating disorder inventory total, cortisol to interpersonal distrust. 
ED Purging women showed positive correlations between CBG and interoceptive awareness, bulimia, 
ineffectiveness, ascetism, and eating disorder inventory total; aspartate aminotransferase to 
interpersonal distrust, ineffectiveness and perfectionism;, urea to interoceptive awareness, lactic 
dehydrogenase to perfectionism, , uric acid to body dissatisfaction, glucose and alanine 
aminotransferase to ineffectiveness, deoxycortisol to interpersonal distrust and social insecurity. 
Negative correlations for purging ED women were centered on SHBG, which correlated with 
interoceptive awareness, bulimia, ineffectiveness, maturity fears, impulse regulation, ascetism, social 
insecurity, and eating disorder inventory total. Other negative correlations were: pregnelonone to drive 
for thinness, aldosterone to body dissatisfaction, height to maturity fears, albumin to ascetism. 
CG showed negative correlations for deoxycortisol to drive for thinness, body dissatisfaction, bulimia, 
and impulse regulation; BMI to drive for thinness, body dissatisfaction and perfectionism, body fat to 
drive for thinness and perfectionism, HOMA to ineffectiveness, maturity fears and social insecurity, 
glucose to maturity fears, social insecurity and eating disorder inventory total, plasma proteins to 
maturity fears, CBG to impulse regulation, bilirrubin to eating disorder inventory total,  
Negative correlations for control women were cortisol and cortisone to body dissatisfaction, estrone 
sulfate to drive for thinness,  
On Table 3 only the global severity index of the SCL90R test is shown. ED non-purging women showed 
correlations for total protein and albumin, and negative correlation for alanine aminotransferase. In 
purging women, the correlation was positive for CBG and negative for SHBG. The CG showed only 
positive correlations for both glucose and bilirubin. 
 
Discussion 
The present study aimed to explore whether specific ED cluster of patients (purging vs. non-purging) 
are differentiated on hormonal-metabolic parameters, when compared with healthy-eating controls, and 
to analyze whether there is an interaction between the hormonal-metabolic functioning and phenotypical 
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features (purging behaviour, eating and general psychopathology) in ED patients. Our observations 
indicate that potentially meaningful correlations do exist between eating severity and general 
psychopathology and specific hormonal and metabolic functioning, and that purging and non-purging 
subjects respond in a different hormonal-metabolic way. 
When comparing the absolute mean values of the items analyzed between the three experimental 
groups we observed only small differences if any. The limited number of significant differences between 
purgative and non-purgative groups (and from these and the CG), suggest that most of the 
psychometric hormonal and metabolic data presented fall well within the limits of “normalcy”. There 
were no marked differences due to purging behavior, and neither were (considering only the metabolic 
and hormonal parameters) between controls and patients with a clinically defined eating disease. This 
was also expected, since most of the subjects’ weight was normal and there were no deviations from 
the range of normalcy as those observed in deeply altered hormonal states. These results are 
comparable to a number of similar studies in which there were no marked effects of ED on most 
metabolic indicators other than those expected by altered food intake (36). Nevertheless, genetic 
studies have shown a number of allele distributions closely related with eating disorders (37,38), and, 
evidently, gene expression ultimately translates into metabolic effects. 
The application of a deeper-layer analysis of possible correlations between the data, i.e. determining the 
possible differences in relationships between different parameters showed distinct patterns between 
both psychometric and metabolic factors, in a way that clearly differentiated the three groups. The 
statistically defined association of parameters helps explain the basic patterns of change, often 
obliterated in direct comparisons by the “noise” of human variability, individual specificity of the eating 
disorder and the variability inherent to the analytical techniques. 
Purging behavior is a key diagnostic element for the classification of the eating disorders and is a 
distinct qualitative and qualifying trait (22,24). The application of the statistical correlation analysis to a 
sample of eating-disordered women on the basis of purging behavior resulted in two well marked 
behavioral patterns that transcend the simple sharing of ED diagnostic categories. However, the most 
important finding is that these different patterns associated with purging behavior are also closely 
correlated with a number of hormonal and metabolic parameters in a well differentiated pattern. 
11 
 
We centered a large part of the efforts for this study on the analysis of a large number of steroid 
hormones because of their relationship with behavior (39,40) and their alterations under stress (41) 
depression-like conditions (42,43), sexual drive, cycles (44) and role-related behavior (45). In the obese, 
estrone levels are a correlate of body fat (46). Estradiol facilitates fat mobilization (47) and controls 
gonadotropin synthesis in the brain (48). Testosterone is an important controller of sexual behavior in 
women (49), and competes with estradiol for binding to SHBG (50). Unfortunately, most values for 
testosterone were below the limit of detection of the methodology used, which at least allows us to 
prove that the analyzed women had normal or lower than normal levels of testosterone; whereas those 
of estradiol were within the normal range (51). Glucocorticoids are affected by rhythms (52), control 
energy metabolism (53) and the immune response to inflammation (54). Cortisol is carried in blood 
mainly by CBG (55), which also helps modulate the corticosteroid response (56,57). 
Purging is clearly associated with hormone function, as shown by the positive correlation of ED 
psychopathology and general psychopathology with CBG levels and their negative relationship with 
SHBG, traits not observed in CG of ED non-purging. The levels of estradiol were lower in non-purging 
than in CG, but unaffected in ED purging, which also showed higher levels of SHBG than either group. 
A trend to increase SHBG levels as that observed in purging women may result in lower availability of 
free sex hormones and is in line with the SHBG increase under conditions of malnutrition and anorexia 
(58,59). Estradiol is probably SHBG main binding hormone, since testosterone levels were very low in 
all cases, but its levels did not show significant differences between groups. These findings confirm a 
marked reversed interrelationship between purging and SHBG. However, it is unclear how SHBG may 
help define the metabolic profile of purging women.  
The case for CBG mirrors that of SHBG, but now the correlations of CBG with purging and of 
deoxycortisol in non-purging ED patients were positive.  
The inactive/active corticosteroid (cortisone/cortisol) concentrations ratio was 17.5 for non-purging, 19.9 
for purging and 24.1 for CG (p<0.01 for ED and non-purging, and p<0.05 for purging). This difference 
points to an overall increased reconversion of inactive cortisone into active cortisol via 11β-
hydroxysteroid dehydrogenase (17,41) in the ED patients, irrespective of the purgative factor analyzed 
here. This may represent a mechanism of homoeostatic preservation or increased hormone turnover 
rather than a direct increase in hormone activity, since cortisol levels were normal in all three groups 
12 
 
The high correlations of purging ED with CBG and the unchanged ratio of CBG versus cortisol in all 
three groups suggests that in purging women there may be relatively maintained (but tighter) activity of 
glucocorticoids when compared with CG. The correlations of corticosteroid activity, including CBG hint 
at them to play a role in the particular behavioral act of purging, in parallel to their implication in stress, 
and on most reactions to harm, external interaction and depression (60,61).  
The positive correlations of BMI, body weight, body fat, albumin and other indicators of possible 
tendency to excess of nutrients were in part shared by CG, and clearly reflect both the trend to increase 
food intake (repeated correlations with BMI, free fatty acids and albumin in non-purging and BMI, 
glucose, uric acid in CG),  andconcerns with eating and weight . However, the remarkable and repeated 
negative correlation with aspartate aminotransferase, an index of liver failure (62) may suggest that 
there is not an excessive “excess” of nutrients driving to a complicated situation such as liver steatosis, 
obesity or other metabolic syndrome components. In non purging women, metabolic control seems 
tighter than in CG, and the negative correlations with aminotransferases contrast with the positive 
correlations found in purging women. 
Positive correlations in the purging women show a disturbing assortment of markers of liver dysfunction 
(serum aminotransferases, urea, uric acid, lactic dehydrogenase). None of these parameters is out of 
the normalcy range, but their association suggests that the purging behavior is a harbinger of possible 
future hepatic alterations. Evidently, the loss of electrolyte and the upper GI tract damage induced by 
forced vomiting (63) can elicit protracted negative consequences, but the possible implication of the liver 
has not yet been established. The data presented here suggest a need for the control of liver well being 
in the EDs associated with purging. 
The ED components of the purging women may be translated in a deep preoccupation by their image, 
bulimia and the ability to act against its consequences, i.e. the decision to vomit. Probably in this second 
active part is where the relative lowering of estrogenic function may help favor a more action-prone 
brain setting (64). Bulimic behavior is again negatively associated to SHBG levels (unpublished results), 
reinforcing the notion that there is an inverse relationship between the impulse to act and SHBG levels, 
i.e. higher free circulating sex hormones. The lack of correlation with parameters more directly related 
with body weight and shape suggests that purging behavior is not a simple component of the drive 
eliminate excess energy intake, but is rooted in sex hormone/ glucocorticoid functional relationships. 
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In the non-purging group the ED substrate is the same (body dissatisfaction, bulimia), but the fear for 
the consequences was greater than the drive for action. There was no correlation with sex hormones or 
their transporting globulin, no metabolic correlations with liver function indexes, but a number of positive 
correlations with BMI, body fat and free fatty acids. This reflects a more “normal” approach to the 
problem of bulimia, and a lot more of passiveness on the part of the patient with respect to the eventual 
consequences. The image problem, however, persists because no “actions” are taken, and as a 
consequence the metabolic derangements associated with these actions did not appear; or at least not 
more than in CG, which EDI2 responses were also fairly well correlated with BMI, HOMA and body fat. 
Since the BMI of non-purging women was higher than that of CG (probably, at least in part, 
consequence of the combination of bulimia and not purging), but in the limit of normalcy and overweight, 
no significant alteration in the insulin-glucose handling (HOMA) can be appreciated. Controls, however, 
showed deeper correlations for these parameters in the absence of both overweight and bulimia, which 
suggests that other factors may probably help protect the non-purging women from the unbalancing of 
glycemia / insulinemia. 
The differential degrees of interaction between psychopathology, (both eating and general), and the 
hormonal functioning, when considered purging and non-purging women, suggest that both disorders 
have not only phenotypical and symptomatological differences, but also may have some differential 
underlying biological functioning. 
Psychopathology, and indirectly degree of severity in ED, and reproductive steroid hormones may 
interact and reinforce each other. This finding is in concordance with previous studies were sex 
hormones, not only played a role in brain development, but also were associated to general 
psychopathology and mental disorders (65,66).  
In sum, the data presented show that correlations of selected eating and general psychopathological 
symptoms with BMI in non-purging and the CBG and SHBG correlations in purging may eventually 
result in possible markers of this aspect of the disorder. The application of this approach may provide 
additional clues for understanding the pathogenesis and development of the eating diseases. The 
recommendation for long-term control of liver function in purging women is also a conclusion that can be 
drawn from this study.  
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Metabolic correlates, thus, provide a physiological substrate to the psychological findings and may help 
unravel the mechanisms that define these behavioral traits despite the interference of variability, 
personality factors and complexity of the task. 
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Table 1 – Mean values for the EDI2 and SCLR90R test items of controls, and ED purging and non-purging women. 
parameter ED non-purging ED purging controls statistical significance 
C-ED 
 
C-NP C-P P-NP 
EDI2 test 
drive for thinness 15.4 ± 1.2 (18) 16.06 ± 1.02 (33) 2.70 ± 1.31 (10) *** *** ***  
body dissatisfaction 18.2 ± 1.8 (18) 17.82 ± 1.43 (33) 7.7 ± 3.5 (10) *** ** **  
interoceptive awareness 13.9 ± 1.5 (18) 13.12 ± 1.19 (33) 2.10 ± 0.64 (10) *** *** ***  
bulimia 5.39 ± 1.36 (18) 8.70 ± 0.99 (33) 0.50 ± 0.34 (10) *** * ***  
interpersonal distrust 7.78 ± 1.48 (18) 5.06 ± 0.96 (33) 2.00 ± 0.75 (10) * **   
ineffectiveness 12.72 ± 1.95 (18) 11.33 ± 1.13 (33) 3.50 ± 1.05 (10) *** ** ***  
maturity fears 9.56 ± 1.27 (18) 7.76 ± 0.93 (33) 3.70 ± 1.36 (10) ** ** *  
perfectionism 7.22 ± 1.16 (18) 5.70 ± 0.74 (33) 2.00 ± 0.92 (10) ** ** *  
impulse regulation 8.33 ± 1.76 (18) 7.91 ± 1.34 (33) 0.30 ± 0.21 (10) ** ** **  
ascetism 8.72 ± 0.98 (18) 8.18 ± 0.76 (33) 3.10 ± 0.59 (10) *** *** ***  
social insecurity 8.78 ± 1.46 (18) 7.48 ± 0.79 (33) 3.40 ± 0.95 (10) ** * *  
eating disorder inventory total 116 ± 11 (18) 109 ± 8 (33) 31.0 ± 6.9 (10) *** *** ***  
SCLR90R test 
global severity index 1.96 ± 0.20 (18) 2.06 ± 0.12 (31) 0.56 ± 0.12 (10) *** *** ***  
positive symptom index 69 ± 4 (18) 72 ± 2 (31) 33.4 ± 5.69 (10) *** *** ***  
positive symptom distress index 2.48 ± 0.16 (18) 2.54 ± 0.09 (31) 1.46 ± 0.10 (10) *** *** ***  
 
The data are mean ± sem; the number of values (N) for each parameter is given between parentheses. Statistical significance of the differences between 
groups (Student’ts t test): * = P<0.05; ** = P<0.01; ***=P<0.001. C-ED = comparison of control and all ED patients; C-NP = comparison between CG and 
non-purging; C-P = comparisons between CG and purging; P-NP = comparisons between purging and non-purging groups 
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 Table 2– Mean values for the serum steroid hormone-related data of controls, and ED purging and non-purging women. 
parameter units ED non-purging ED purging controls 
statistical significance 
C-ED  C-NP C-P P-NP 
estrone pM 0.24 ± 0.02 (19) 0.25 ± 0.03 (34) 0.35 ± 0.07 (18)     
estrone sulfate nM 6.02 ± 0.63 (18) 6.74 ± 0.78 (33) 8.80 ± 0.90 (17) * *   
β-estradiol pM 0.27 ± 0.04 (20) 0.47 ± 0.10 (34) 0.45 ± 0.06 (18)  *   
estriol     [A] pM 0.06 ± 0.03 (3/16) 0.01 ± 0.01 (4/30) 0.01 ± 0.00 (2/16)     
cortisone nM 56.8 ± 4.4 (20) 56.1 ± 2.6 (33) 66.3 ± 5.0 (17) *    
cortisol nM 325 ± 30 (20) 282 ± 19 (33) 275 ± 32 (17)     
deoxycortisol pM 5.41 ± 2.92 (16/3) 2.84 ± 0.65 (23/11) 3.90 ± 1.30 (8/8)     
androstenedione pM 9.62 ± 1.51 (11/8) 4.88 ± 0.43 (19/15) 3.69 ± 0.69 (10/7) * **  *** 
DHEA-sulfate µM 6.37 ± 0.66 (21) 4.80 ± 0.44 (35) 5.56 ± 0.37 (17)    * 
testosterone    [A] pM <0.6  (0/21) <0.6 (0/35) 1.82 (1/17)     
17OH-progesterone    [A] pM <6.0 (0/21) 11.3 ± 2.7 (5/29) 19.5 ± 7.6 (2/16)     
progesterone pM 17.7 ± 6.2 (4/15) 23.0 ± 5.5 (15/19) 25.9 ± 5.5 (8/10)     
pregnelonone    [A] pM 26.4 ± 7.0 (6/13) 62.2 ± 26.8 (7/27) 14.6 (1/17)     
SHBG nM 46.2 ± 5.8 (21) 56.0 ± 5.2 (35) 39.0 ± 4.1 (18)   *  
CBG nM 1202 ± 66 (21) 1181 ± 49 (35) 1083 ± 39 (18)     
 
The data are mean ± sem; the number of values (N) for each parameter is given between parentheses. Statistical significance of the differences between 
groups (Student’ts t test): * = P<0.05; ** = P<0.01; ***=P<0.001. C-ED = comparison of control and all ED patients; C-NP = comparison between CG and 
non-purging; C-P = comparisons between CG and purging; P-NP = comparisons between purging and non-purging groups 
NOTES: [A] The data in these rows show only the mean of the values measured that were actually over the limit of detection of the hormone; in 
consequence they are not representative of the actual values, largely closer to that limit of detection, i.e. “not detected”. We allowed these figures only as an 
indication of the differences (or lack of) between groups; in these cases, a second N value, in italics, is included to indicate how many samples were below 
the limit of detection of the test. 
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Table 3 - Correlations between components of the EDI2  and SCL90R tests with hormonal, anthropometric and metabolic parameters in a group of controls 
and women with eating diseases with respect to the purging or non-purging nature of their disease 
 
 acronym 
ED- non-purging (N=24-26) ED-purging (N=33-36) control  group (N=17-18) 
+ correlation – correlation + correlation – correlation + correlation – correlation 
drive for thinness DT    pregnenolone9 
BMI· deoxycortisol8 
body-fat · estrone-sulfate 
body dissatisfaction BD BMI · body weight · body fat  uric acid aldosterone19 BMI · 
deoxycortisol8 
cortisol · cortisone 
interoceptive 
awareness IA  
AspT CBG · urea SHBG   
bulimia B 
BMI ·body weight · AlaT · 
body fat · insulin · HOMA  CBG SHBG deoxycortisol
8  




AspT    
ineffectiveness I free-fatty-acids·deoxycortisol AspT 
CBG · glucose · 
HOMA · AspT    
AlaT 
SHBG HOMA  
maturity fears MF    SHBG · height glucose · HOMA · plasma-proteins  
perfectionism P albumin  AspT · LDH  BMI · body-fat  
impulse regulation IR deoxycortisol   progesterone
8  
free-fatty-acids AspT  SHBG 
uric acid · CBG · 
deoxycortisol8  
ascetism A deoxycortisol   androstenedione  free-fatty-acids  CBG SHBG · albumin   
social insecurity SI deoxycortisol· free-fatty-acids AspT deoxycortisol SHBG glucose · HOMA  
EDI2 total scores EDI urea ·plasma-proteins· albumin AspT CBG SHBG glucose · bilirubin  
SCL90R 
Global severity index GSI total protein·  albumin  urea AspT CBG SHBG glucose · bilirrubin - 
 
Only significant correlations (p<0.05) have been included; data in bold correspond to p<0.01. Data for most hormones values were calculated from a lower 
number of individuals because of lower-than-threshold measurements obtained in a number of subjects; superscript figures indicate a low number (N) of 





SUPPLEMENTARY ONLINE MATERIAL 
Figure 1 
Steroid hormones that have been analyzed in the present study and their overall metabolic relationships. 




Analysis of hormones by HPLC-MS/MS 
Hormone standards were obtained from Steraloids (Newport RI USA) and Sigma (St Louis MO USA), and 
the deuterated internal standards from CDN Isotopes (Pointe Claire Ontario Canada). Chromatographic-
grade solvents were from Riedel de Haën (Seelze Germany). Calibration curves were prepared for all 
steroid hormones in the range 1 to 4000 nM. The ratio between the peak area of each endogenous steroid 
and the deuterated steroid standard was correlated with the concentration using linear regression analysis 
to quantify serum steroid levels. 
All samples were measured by HPLC-MS/MS in single continuous batches for each group of hormones, 
with a number of blanks and standards interspersed between the samples in order to obtain a good degree 
of homogeneity in the measurements. Three sets of serum samples (0.400 mL each, in duplicate) were 
used. The first was duped with 0.010 mL of 50 nM d4-estrone and 25 nM d4-estradiol as internal 
standards. Samples were extracted with 2 mL dichloromethane. The organic phase was dried under a 
gentle nitrogen stream; dry residues were resuspended in 0.075 mL of 100 mM bicarbonate buffer. pH 
10.5. and 0.075 mL of 1g/L dansyl-chloride (Sigma) in acetone (1) were added, then vortexed and 
incubated 5 min at 60  C. This suspension was directly injected to the HPLC-MS/MS system. 
The second set of samples (0.400 mL) was loaded with 0.025 mL of 1 μM d7-androstenedione and 1 μM 
d2-testosterone as internal standards. Samples were extracted with 1.5 mL acetonitrile; the organic phase 
was dried with nitrogen and re-suspended in 0.120 mL of 5 mM ammonium acetate buffer containing 1g/L 
formic acid. pH 4.0. This suspension was directly injected to the HPLC-MS/MS system. 
The third set of serum samples (0.400 mL) were mixed with 0.025 mL of a working stock mixture of d8-
cortisol (1x10-5 M) added as an internal standard, and the tubes were incubated on ice for 20 min. 
Acetonitrile (1.5 mL) was then added and the tubes were vortexed and centrifuged to remove proteins. 
Supernatants were transferred into glass tubes and evaporated to dryness under nitrogen; dried residues 
were re-dissolved in 0.120 mL of the mobile phase, which was injected to the HPLC-MS/MS system. 
Sample analyses were performed by LC-MS/MS (Varian. Palo Alto. CA. USA) in an instrumental setup 
consisting of: 210 pump with an on-line degassifier, 410 autosampler, and 1200L triple quadrupole mass 
spectrometer equipped with an electrospray ionization (ESI) source operated in positive ion mode. 
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Chromatographic separation was carried out using an Atlantis column 50 x 2.1 mm 3 µm (Waters, Milford 
USA) at 0.3 mL/min for estrogens, and an Inertsil ODS-3 column 150 x 3.0 mm 3 µm (Varian) at 0.2 
mL/min for androgens. The eluent for estrogens was: a) 95% water-5% acetonitrile (with 0.1% formic acid). 
b) 95% acetonitrile-5% water (with 0.1% formic acid). The gradient (for b) was: min 0: 70 %. min 0.24-2: 
85%. min 2-3.3: 85-95%. min 3.3-4: 95-70%. min 4-7: 70 %.  
The eluent for androgens was: a) 5 mM ammonium acetate (with 0.1% formic acid). b) acetonitrile. The 
gradient (for b) was: min 0-28: 30 55 %. min 28-32: 55 90 %. min 32-48: 90 %. min 48-50: 90 30 %. min 50-
55: 30 %.  
The limit of sensitivity for estrogens (referred to serum) was established at 25 pM. The limit of sensitivity for 
both androgens was set at 0.6 nM. Interassay precision for hormone analyses within the present range of 
measurement were: 20% estrone, 21 % estradiol, 16% androstenedione, and 17% testosterone. 
The chromatographic separation of corticosteroids was performed in a 150 x 3.0 (i.d.) mm Intersil 3 ODS-3 
column (Varian, Palo Alto CA USA). The mobile phase consisted of two eluents, solvent a (5mM 
ammonium acetate. 0.1% formic acid) and solvent b (acetonitrile), at a flow rate of 0.2 mL/min. Samples of 
0.050 mL were injected into the LC-MS/MS, after which the injector was washed five times with mobile 
phase. The total run time was 55 min. A linear gradient from 30% to 55% b was programmed for the first 28 
min, followed by a second linear gradient to 90% b for 4 min. and isocratic mode for the next 16 min. Then, 
the system was returned to the initial proportion of 30% solvent b over the following 2 min and maintained 
for the final 5 min of each run.  Detection limits of the method (referred to serum) were 2 nM for cortisol and 
10 nM for cortisone. 
Reference 
1. Anari MR, Bakhtiar R, Zhu B, Huskey S, Franklin RB, Evans DC. Derivatization of ethinylestradiol 
with dansyl chloride to enhance electrospray ionization: aplication in trace analysis of ethinylestradiol 






Supplementary Table 1. Mean values for the anthropometric parameters of controls, and ED purging and non-purging women. 
parameter units ED non-purging ED purging controls 
Age years 31.3 ± 1.9 (21) 28.5 ± 1.5 (35) 33.4 ± 2.1 (17) 
Weight kg 69.0 ± 6.2 (18) 61.1 ± 3.3 (30) 55.8 ± 1.9 (15) 
Height m 1.63 ± 0.01 (18) 1.61 ± 0.01 (30) 1.61 ± 0.01 (15) 
BMI kg/m2 25.8 ± 2.2 (18) 23.5 ± 1.2 (30) 21.5 ± 0.7 (15) 
Body fat % 29.8 ± 3.1 (13) 21.0 ± 3.3 (16) 22.1 ± 1.9 (15) 
 
 
The data are mean ± sem; the number of values (N) for each parameter is given between parentheses.. The only significant difference between groups 







Supplementary Table 2.  Mean values for other serum metabolic data of controls, and ED purging and non-purging women. 
parameter units ED non-purging ED purging ED controls 
glucose mM 6.41 ± 0.93 (21) 5.23 ± 0.18 (35) 5.73 ± 0,27 (17) 
insulin pM 66.2 ± 7.9 (21) 55.7 ± 3.2 (35) 64.3 ± 5.4 (16) 
HOMA index  3.65 ± 0.96 (21) 2.16 ± 0.14 (35) 2.74 ± 0.28 (16) 
total cholesterol mM 4.63 ± 0.26 (21) 4.52 ± 0.16 (35) 4.81 ± 0.22 (18) 
urea 
 
mM 2.03 ± 0.11 (21) 1.91 ± 0.10 (35) 2.10 ± 0.12 (18) 
total bilirubin 
 
μM 15.8 ± 1.4 (21) 13.9 ± 0.8 (35) 16.9 ± 1.5 (18) 
aspartate aminotransferase nkat/l 348 ± 20 (21) 334 ± 19 (35) 317 ± 30 (18) 
alanine aminotransferase 
 
nkat/l 373 ± 93 (21) 232 ± 16 (35) 282 ± 42 (17) 
lactate dehydrogenase μkat/l 6.01 ± 0.36 (21) 5.84 ± 0.32 (35) 5.37 ± 0.34 (17) 
total protein 
 
g/l 68.9 ± 3.0 (21) 69.8 ± 1.5 (35) 72.6 ± 2.3 (18) 
albumin 
 
g/l 47.9 ± 2.4 (21) 49.5 ± 1.0 (35) 48.0 ± 2.4 (18) 
triacylglycerols 
 
mM 1.00 ± 0.23 (21) 0.824 ± 0.07 (35) 0.69 ± 0.06 (18) 
uric acid 
 
μM 261 ± 16 (21) 270 ± 10 (35) 271 ± 14 (18) 
free fatty acids 
 
mM 0.60 ± 0.07 (21) 0.60 ± 0.07 (35) 0.58 ± 0.06 (18) 
 
The data are mean ± sem; the number of values (N) for each parameter is given between parentheses. There were no statistically significant differences 
between groups (Student’ts t test). 
 
